US Stock MarketDetailed Quotes

KYMR Kymera Therapeutics

Watchlist
  • 41.400
  • +1.170+2.91%
Trading Jan 2 09:56 ET
2.68BMarket Cap-17.69P/E (TTM)

Kymera Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Jan 2, 2025

Based on 15 analysts giving stock ratings to Kymera Therapeutics in the past 3 months

Strong Buy

  • Buy

    86.67%

  • Hold

    13.33%

  • Sell

    0.00%

Price Target

Updated: Jan 2, 2025

The average Kymera Therapeutics stock price target is 58.29 with a max estimate of 74.00 and a min estimate of 49.00

Review Kymera Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Jan 2, 2025

Strong Buy

  • Buy

    86.67%

  • Hold

    13.33%

  • Sell

    0.00%

Price Target

Updated: Jan 2, 2025

Heat List
US
Overall
Symbol
Price
% Chg

No Data